These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 20860640

  • 21. Atrial fibrillation and anticoagulation.
    Maxim R.
    Med Health R I; 2001 Mar; 84(3):96-7. PubMed ID: 11280139
    [No Abstract] [Full Text] [Related]

  • 22. Antithrombotic treatment in atrial fibrillation.
    Lip GY, Boos CJ.
    Postgrad Med J; 2008 May; 84(991):252-8. PubMed ID: 18508982
    [Abstract] [Full Text] [Related]

  • 23. Warfarin and aspirin use and the predictors of major bleeding complications in atrial fibrillation (the Framingham Heart Study).
    Sam C, Massaro JM, D'Agostino RB, Levy D, Lambert JW, Wolf PA, Benjamin EJ, Framingham Heart Study.
    Am J Cardiol; 2004 Oct 01; 94(7):947-51. PubMed ID: 15464686
    [Abstract] [Full Text] [Related]

  • 24. Hospitalized patients with atrial fibrillation compared to those included in recent trials on novel oral anticoagulants: a population-based study.
    Joppi R, Cinconze E, Mezzalira L, Pase D, Poggiani C, Rossi E, Pengo V, Italian Horizon Scanning Project.
    Eur J Intern Med; 2013 Jun 01; 24(4):318-23. PubMed ID: 23528931
    [Abstract] [Full Text] [Related]

  • 25. Risks and benefits of combining aspirin with anticoagulant therapy in patients with atrial fibrillation: an exploratory analysis of stroke prevention using an oral thrombin inhibitor in atrial fibrillation (SPORTIF) trials.
    Flaker GC, Gruber M, Connolly SJ, Goldman S, Chaparro S, Vahanian A, Halinen MO, Horrow J, Halperin JL, SPORTIF Investigators.
    Am Heart J; 2006 Nov 01; 152(5):967-73. PubMed ID: 17070169
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Antithrombotic therapies for stroke prevention in atrial fibrillation.
    Economides Muñoz C, Singh BN.
    Minerva Cardioangiol; 2004 Apr 01; 52(2):125-39. PubMed ID: 15194994
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Short-term prevention of thromboembolic complications in patients with atrial fibrillation with aspirin plus clopidogrel: the Clopidogrel-Aspirin Atrial Fibrillation (CLAAF) pilot study.
    Lorenzoni R, Lazzerini G, Cocci F, De Caterina R.
    Am Heart J; 2004 Jul 01; 148(1):e6. PubMed ID: 15215815
    [Abstract] [Full Text] [Related]

  • 31. Oral anticoagulation in nonvalvular atrial fibrillation in clinical practice: impact of CHADS(2) score on outcome.
    Ruiz Ortiz M, Romo E, Mesa D, Delgado M, Anguita M, Castillo JC, Arizón JM, Suárez de Lezo J.
    Cardiology; 2010 Jul 01; 115(3):200-4. PubMed ID: 20160440
    [Abstract] [Full Text] [Related]

  • 32. Comparison of bleeding in patients with nonvalvular atrial fibrillation treated with ximelagatran or warfarin: assessment of incidence, case-fatality rate, time course and sites of bleeding, and risk factors for bleeding.
    Douketis JD, Arneklev K, Goldhaber SZ, Spandorfer J, Halperin F, Horrow J.
    Arch Intern Med; 2006 Apr 24; 166(8):853-9. PubMed ID: 16636210
    [Abstract] [Full Text] [Related]

  • 33. Platelet adhesion in atrial fibrillation.
    Choudhury A, Chung I, Blann A, Lip GY.
    Thromb Res; 2007 Apr 24; 120(4):623-9. PubMed ID: 17250878
    [Abstract] [Full Text] [Related]

  • 34. Treatment of atrial fibrillation and atrial flutter: Part II.
    Aronow WS.
    Cardiol Rev; 2008 Apr 24; 16(5):230-9. PubMed ID: 18708824
    [Abstract] [Full Text] [Related]

  • 35. Bleeding during antithrombotic therapy in patients with atrial fibrillation. The Stroke Prevention in Atrial Fibrillation Investigators.
    Arch Intern Med; 1996 Feb 26; 156(4):409-16. PubMed ID: 8607726
    [Abstract] [Full Text] [Related]

  • 36. Antiplatelet agents, warfarin, and epidemic intracranial hemorrhage.
    Siracuse JJ, Robich MP, Gautam S, Kasper EM, Moorman DW, Hauser CJ.
    Surgery; 2010 Oct 26; 148(4):724-9; discussion 729-30. PubMed ID: 20727562
    [Abstract] [Full Text] [Related]

  • 37. Glomerular filtration rate in patients with atrial fibrillation on warfarin treatment: a subgroup analysis from the AURICULA registry in Sweden.
    Jönsson KM, Wieloch M, Sterner G, Nyman U, Elmståhl S, Engström G, Svensson PJ.
    Thromb Res; 2011 Oct 26; 128(4):341-5. PubMed ID: 21620441
    [Abstract] [Full Text] [Related]

  • 38. [Atrial fibrillation due to non-valvular causes: indications for antithrombotic therapy].
    Codinach Huix P.
    Med Clin (Barc); 1996 Apr 20; 106(15):586-9. PubMed ID: 8656759
    [No Abstract] [Full Text] [Related]

  • 39. Predictors of warfarin use among Ohio medicaid patients with new-onset nonvalvular atrial fibrillation.
    Johnston JA, Cluxton RJ, Heaton PC, Guo JJ, Moomaw CJ, Eckman MH.
    Arch Intern Med; 2003 Jul 28; 163(14):1705-10. PubMed ID: 12885686
    [Abstract] [Full Text] [Related]

  • 40. Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation.
    Hylek EM, Go AS, Chang Y, Jensvold NG, Henault LE, Selby JV, Singer DE.
    N Engl J Med; 2003 Sep 11; 349(11):1019-26. PubMed ID: 12968085
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.